Padian Nancy S, van der Straten Ariane, Ramjee Gita, Chipato Tsungai, de Bruyn Guy, Blanchard Kelly, Shiboski Stephen, Montgomery Elizabeth T, Fancher Heidi, Cheng Helen, Rosenblum Michael, van der Laan Mark, Jewell Nicholas, McIntyre James
University of California, San Francisco, CA, USA.
University of California, San Francisco, CA, USA.
Lancet. 2007 Jul 21;370(9583):251-261. doi: 10.1016/S0140-6736(07)60950-7.
Female-controlled methods of HIV prevention are urgently needed. We assessed the effect of provision of latex diaphragm, lubricant gel, and condoms (intervention), compared with condoms alone (control) on HIV seroincidence in women in South Africa and Zimbabwe.
We did an open-label, randomised controlled trial in HIV-negative, sexually active women recruited from clinics and community-based organisations, who were followed up quarterly for 12-24 months (median 21 months). All participants received an HIV prevention package consisting of pre-test and post-test counselling about HIV and sexually transmitted infections, testing, treatment of curable sexually transmitted infections, and intensive risk-reduction counselling. The primary outcome was incident HIV infection. This study is registered with ClinicalTrials.gov, number NCT00121459.
Overall HIV incidence was 4.0% per 100 woman-years: 4.1% in the intervention group (n=2472) and 3.9% in the control group (n=2476), corresponding to a relative hazard of 1.05 (95% CI 0.84-1.32, intention-to-treat analysis). The proportion of women using condoms was significantly lower in the intervention than in the control group (54%vs 85% of visits, p<0.0001). The proportions of participants who reported adverse events (60% [1523] vs 61% [1529]) and serious adverse events (5% [130] vs 4% [101]) were similar between the two groups.
We observed no added protective benefit against HIV infection when the diaphragm and lubricant gel were provided in addition to condoms and a comprehensive HIV prevention package. Our observation that lower condom use in women provided with diaphragms did not result in increased infection merits further research. Although the intervention seemed safe, our findings do not support addition of the diaphragm to current HIV prevention strategies.
迫切需要女性主导的艾滋病预防方法。我们评估了提供乳胶隔膜、润滑剂凝胶和避孕套(干预组)与仅提供避孕套(对照组)相比,对南非和津巴布韦女性艾滋病血清感染率的影响。
我们在从诊所和社区组织招募的HIV阴性、有性行为的女性中进行了一项开放标签的随机对照试验,对她们每季度随访12 - 24个月(中位数为21个月)。所有参与者都接受了一个艾滋病预防套餐,包括关于艾滋病和性传播感染的检测前和检测后咨询、检测、可治愈性传播感染的治疗以及强化的风险降低咨询。主要结局是新发艾滋病感染。本研究已在ClinicalTrials.gov注册,注册号为NCT00121459。
总体艾滋病发病率为每100女性年4.0%:干预组(n = 2472)为4.1%,对照组(n = 2476)为3.9%,意向性分析得出相对风险为1.05(95%可信区间0.84 - 1.32)。干预组使用避孕套的女性比例显著低于对照组(就诊时分别为54%和85%,p < 0.0001)。两组报告不良事件的参与者比例(60% [1523]对61% [1529])和严重不良事件的比例(5% [130]对4% [101])相似。
除了避孕套和全面的艾滋病预防套餐外,再提供隔膜和润滑剂凝胶时,我们未观察到对艾滋病感染有额外的保护益处。我们观察到,配备隔膜的女性中避孕套使用率较低,但并未导致感染增加,这一现象值得进一步研究。尽管干预措施似乎是安全的,但我们的研究结果不支持在当前的艾滋病预防策略中增加隔膜。